Adaptive Biotechnologies (ADPT) Inventory (2018 - 2026)

Adaptive Biotechnologies has disclosed Inventory across 9 years of filings, most recently posting $11.2 million for Q1 2026.

• Inventory for Q1 2026 came in at $11.2 million, up 29.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.2 million (up 29.04% YoY), and the FY2025 annual result was $9.8 million, up 16.35% from the prior year.
• Inventory came in at $11.2 million for Q1 2026 at Adaptive Biotechnologies, up from $9.8 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $21.0 million in Q1 2022 to a low of $8.4 million in Q2 2025.
• The 5-year median for Inventory is $13.3 million (2024), against an average of $14.1 million.
• Across the five-year window, Inventory sank 41.58% in 2024 and grew 29.04% in 2026, its largest moves.
• Adaptive Biotechnologies' Inventory stood at $14.5 million in 2022, then slipped by 0.03% to $14.4 million in 2023, then plunged by 41.58% to $8.4 million in 2024, then increased by 16.35% to $9.8 million in 2025, then gained by 14.11% to $11.2 million in 2026.
• The last three Inventory figures came in at $11.2 million (Q1 2026), $9.8 million (Q4 2025), and $9.9 million (Q3 2025), per Business Quant data.